Diagnos seeks to extend 6.7 million warrants to June 5, 2027

The proposed amendment would move the expiry from August 5, 2026 while keeping the C$0.40 exercise price unchanged, subject to TSX Venture Exchange approval.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.